This report contains market size and forecasts of Long-Acting Injectables in Global, including the following market information:
Global Long-Acting Injectables Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Long-Acting Injectables market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Long-Acting Injectables companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Long-Acting Injectables Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Long-Acting Injectables Market Segment Percentages, By Type, 2020 (%)
Small and Middle Sized Molecule
Large Sized Molecule
China Long-Acting Injectables Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Long-Acting Injectables Market Segment Percentages, By Application, 2020 (%)
Schizophrenia
Other Psychotic Disorders
Global Long-Acting Injectables Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Long-Acting Injectables Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Long-Acting Injectables Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Long-Acting Injectables Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Eli Lilly
Pfizer
GlaxoSmithKline
Johnson & Johnson
Lupin
Zogenix
DURECT
Medincel
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Long-Acting Injectables Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Long-Acting Injectables Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Long-Acting Injectables Overall Market Size
2.1 Global Long-Acting Injectables Market Size: 2021 VS 2027
2.2 Global Long-Acting Injectables Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Long-Acting Injectables Players in Global Market
3.2 Top Global Long-Acting Injectables Companies Ranked by Revenue
3.3 Global Long-Acting Injectables Revenue by Companies
3.4 Top 3 and Top 5 Long-Acting Injectables Companies in Global Market, by Revenue in 2020
3.5 Global Companies Long-Acting Injectables Product Type
3.6 Tier 1, Tier 2 and Tier 3 Long-Acting Injectables Players in Global Market
3.6.1 List of Global Tier 1 Long-Acting Injectables Companies
3.6.2 List of Global Tier 2 and Tier 3 Long-Acting Injectables Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Long-Acting Injectables Market Size Markets, 2021 & 2027
4.1.2 Small and Middle Sized Molecule
4.1.3 Large Sized Molecule
4.2 By Type - Global Long-Acting Injectables Revenue & Forecasts
4.2.1 By Type - Global Long-Acting Injectables Revenue, 2016-2021
4.2.2 By Type - Global Long-Acting Injectables Revenue, 2022-2027
4.2.3 By Type - Global Long-Acting Injectables Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Long-Acting Injectables Market Size, 2021 & 2027
5.1.2 Schizophrenia
5.1.3 Other Psychotic Disorders
5.2 By Application - Global Long-Acting Injectables Revenue & Forecasts
5.2.1 By Application - Global Long-Acting Injectables Revenue, 2016-2021
5.2.2 By Application - Global Long-Acting Injectables Revenue, 2022-2027
5.2.3 By Application - Global Long-Acting Injectables Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Long-Acting Injectables Market Size, 2021 & 2027
6.2 By Region - Global Long-Acting Injectables Revenue & Forecasts
6.2.1 By Region - Global Long-Acting Injectables Revenue, 2016-2021
6.2.2 By Region - Global Long-Acting Injectables Revenue, 2022-2027
6.2.3 By Region - Global Long-Acting Injectables Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Long-Acting Injectables Revenue, 2016-2027
6.3.2 US Long-Acting Injectables Market Size, 2016-2027
6.3.3 Canada Long-Acting Injectables Market Size, 2016-2027
6.3.4 Mexico Long-Acting Injectables Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Long-Acting Injectables Revenue, 2016-2027
6.4.2 Germany Long-Acting Injectables Market Size, 2016-2027
6.4.3 France Long-Acting Injectables Market Size, 2016-2027
6.4.4 U.K. Long-Acting Injectables Market Size, 2016-2027
6.4.5 Italy Long-Acting Injectables Market Size, 2016-2027
6.4.6 Russia Long-Acting Injectables Market Size, 2016-2027
6.4.7 Nordic Countries Long-Acting Injectables Market Size, 2016-2027
6.4.8 Benelux Long-Acting Injectables Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Long-Acting Injectables Revenue, 2016-2027
6.5.2 China Long-Acting Injectables Market Size, 2016-2027
6.5.3 Japan Long-Acting Injectables Market Size, 2016-2027
6.5.4 South Korea Long-Acting Injectables Market Size, 2016-2027
6.5.5 Southeast Asia Long-Acting Injectables Market Size, 2016-2027
6.5.6 India Long-Acting Injectables Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Long-Acting Injectables Revenue, 2016-2027
6.6.2 Brazil Long-Acting Injectables Market Size, 2016-2027
6.6.3 Argentina Long-Acting Injectables Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Long-Acting Injectables Revenue, 2016-2027
6.7.2 Turkey Long-Acting Injectables Market Size, 2016-2027
6.7.3 Israel Long-Acting Injectables Market Size, 2016-2027
6.7.4 Saudi Arabia Long-Acting Injectables Market Size, 2016-2027
6.7.5 UAE Long-Acting Injectables Market Size, 2016-2027
7 Players Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Corporate Summary
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Long-Acting Injectables Major Product Offerings
7.1.4 Eli Lilly Long-Acting Injectables Revenue in Global (2016-2021)
7.1.5 Eli Lilly Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Long-Acting Injectables Major Product Offerings
7.2.4 Pfizer Long-Acting Injectables Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Corporate Summary
7.3.2 GlaxoSmithKline Business Overview
7.3.3 GlaxoSmithKline Long-Acting Injectables Major Product Offerings
7.3.4 GlaxoSmithKline Long-Acting Injectables Revenue in Global (2016-2021)
7.3.5 GlaxoSmithKline Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Long-Acting Injectables Major Product Offerings
7.4.4 Johnson & Johnson Long-Acting Injectables Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Lupin
7.5.1 Lupin Corporate Summary
7.5.2 Lupin Business Overview
7.5.3 Lupin Long-Acting Injectables Major Product Offerings
7.5.4 Lupin Long-Acting Injectables Revenue in Global (2016-2021)
7.5.5 Lupin Key News
7.6 Zogenix
7.6.1 Zogenix Corporate Summary
7.6.2 Zogenix Business Overview
7.6.3 Zogenix Long-Acting Injectables Major Product Offerings
7.6.4 Zogenix Long-Acting Injectables Revenue in Global (2016-2021)
7.6.5 Zogenix Key News
7.7 DURECT
7.7.1 DURECT Corporate Summary
7.7.2 DURECT Business Overview
7.7.3 DURECT Long-Acting Injectables Major Product Offerings
7.4.4 DURECT Long-Acting Injectables Revenue in Global (2016-2021)
7.7.5 DURECT Key News
7.8 Medincel
7.8.1 Medincel Corporate Summary
7.8.2 Medincel Business Overview
7.8.3 Medincel Long-Acting Injectables Major Product Offerings
7.8.4 Medincel Long-Acting Injectables Revenue in Global (2016-2021)
7.8.5 Medincel Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Long-Acting Injectables Market Opportunities & Trends in Global Market
Table 2. Long-Acting Injectables Market Drivers in Global Market
Table 3. Long-Acting Injectables Market Restraints in Global Market
Table 4. Key Players of Long-Acting Injectables in Global Market
Table 5. Top Long-Acting Injectables Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Long-Acting Injectables Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Long-Acting Injectables Revenue Share by Companies, 2016-2021
Table 8. Global Companies Long-Acting Injectables Product Type
Table 9. List of Global Tier 1 Long-Acting Injectables Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Long-Acting Injectables Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type